Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report
Abstract Background Primary malignant melanoma of the esophagus is a rare form of mucosal melanoma with a poor prognosis. While immune checkpoint inhibitors have recently extended overall survival in metastatic melanoma, data on their effects on primary malignant melanoma of the esophagus are limite...
Main Authors: | Takeshi Okamoto, Eriko Nakano, Teruo Yamauchi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13256-021-02928-w |
Similar Items
-
Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report
by: Shingo Ito, et al.
Published: (2021-05-01) -
Nivolumab induced vitiligo-like depigmentation in metastatic acral lentiginous melanoma
by: Disha Dabbas, et al.
Published: (2019-01-01) -
Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report
by: Yukinori Ozaki, et al.
Published: (2017-11-01) -
Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
by: Koji Yasuda, et al.
Published: (2017-08-01) -
Development of Extragenital Lichen Sclerosus in Malignant Melanoma Patients Treated With Ipilimumab in Combination With Nivolumab
by: S. Morteza Seyed Jafari, et al.
Published: (2020-10-01)